Clinical Study
Quantifying the Increase in Radiation Exposure Associated with SPECT/CT Compared to SPECT Alone for Routine Nuclear Medicine Examinations
Table 2
Average effective dose for the CT portion of the routine nuclear medicine examinations.
| | Study type | No. of patients | Average effective dose (mSv) | Range effective dose (mSv) |
| | 67Gallium | 10 | | 0.4–18.8 | | 99mTc-MDP | 17 | | 0.2–12.4 | | 99mTc-MIBI parathyroid | 78 | | 0.7–8.5 | | 111In-Octreotide | 4 | | 3.7–11.1 | | 111In-WBC | 4 | | 1.4–10.9 | |
Tc99m Ceretec | 2 | | 14.8–15.4 | | 131I Uptake | 35 | | 0.5–12.3 | | 131I Posttherapy Scan | 32 | | 1.1–12.8 | | 111In Chloride (ProstaScint) | 39 | | 3.6–23.3 |
|
|
